Hello friends --I hope this finds you and yours doing well.  I have been to the beach several times recently and that always means my mood and mind space is stellar!!  I'm heading to Nashville for a few days to shoot a few videos re: my experience with MS.  There is wardrobe and hair and makeup involved!!  WHAT!?!?  🥳  Sooo excited.  Home for 4 days then heading to Minnesota for a mini-vacation. Boy do I need it. I'm on the razor's edge of burnout right now.  UGH.Alrighty - let's get to the good stuff:1.  I just posted a new Patients Getting Paid podcast - where I interviewed Kyle Young (no relation!) about his phenomenal success at having his writing published in elite publications like Forbes, Psychology Today, Business Insider, CNBC and others.  Are you interested in pursuing a writing career?? That's PERFECT for a chronicpreneur business!!  Listen in right here:  How to Earn Money from WritingAnd if you're interested in learning how to find and create flexible, remote work that both accommodates your health and generates an income, join us on the inside of the Patients Getting Paid membership right here:  PGP  2.  Interesting study results:  A protein called nephronectin mediates autoimmunity in a mouse model of multiple sclerosis (MS), and blocking this protein was found to prevent disease progression and processes that drive T-cells toward an inflammatory state, researchers reported. Blocking Kidney Protein Prevents Progression in MS Mouse Model3.  This one flips my switch:  A blood biomarker test developed by Octave can effectively monitor overall disease activity in people with multiple sclerosis (MS), helping to improve the care being given, the company reported.  Ummmm, yes, please!!  Blood Test to Monitor MS Activity Supports Optimal Care4.  A single infusion of FibroBiologics‘ investigational cell therapy, CYMS101, was able to inhibit disease activity in a mouse model of multiple sclerosis (MS), and appeared safe in early MS clinical trials, the company announced in a press release.  Fibroblast Cell Therapy Shows Early Promise in MS Patients5.  Where are my Aubagio peeps??  Good news for you, my friends:  More than half of the people with multiple sclerosis (MS) treated with Aubagio (teriflunomide) showed no evidence of disease activity after two years on treatment, according to a study in Italy.  Read all about it: No Disease Activity for 58% of Those on Aubagio After 2 Years: Study6.  A medication currently approved to treat certain kinds of cancer, called topotecan, could be repurposed for treating neuroinflammatory conditions such as multiple sclerosis (MS) because it reduces the inflammatory activity of immune cells called microglia.  Cancer Therapy Topotecan Could Be Repurposed to Treat MS: StudyThat's all folks. Hope you learned something today!  I did!  Is there anything I can help you with???  Drop me an email and let me know at [email protected] or meet me over in the FUMS Facebook community and let's chat!  Thanks.Warmly -- Kathy#FUMS

Sometimes it helps the stress, just to say "F-U-M-S"